Immatics Announces Four Upcoming Oral Presentations Across Its Clinical Cell Therapy and Bispecific Portfolio at 2026 ASCO Annual Meeting

Go back to Immatics Announces Four Upcoming Oral Presentations Across Its Clinical Cell Therapy and Bispecific Portfolio at 2026 ASCO Annual Meeting
(NASDAQ: IMTX) Delayed: 9.38 +0.32 (3.53%)
Previous Close $9.06    52 Week High
Open $9.08    52 Week Low
Day High $9.48    P/E N/A 
Day Low $9.05    EPS
Volume 376,663